Back to top
more

Amgen (AMGN)

(Real Time Quote from BATS)

$321.86 USD

321.86
638,758

+0.07 (0.02%)

Updated Nov 7, 2024 01:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks News

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Ahan Chakraborty headshot

Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock?

NVO's third-quarter revenues are expected to have been driven by its diabetes and obesity care product sales, especially Wegovy, Ozempic and Rybelsus.

Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus

AMGN beats third-quarter estimates for earnings and matches the same for sales. It slightly raises 2024 sales guidance but narrows the EPS range.

Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics

The headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Amgen (AMGN) Beats Q3 Earnings Estimates

Amgen (AMGN) delivered earnings and revenue surprises of 9.20% and 0.04%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Mark Vickery headshot

Top Stock Reports for Costco, Coca-Cola & T-Mobile US

Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), The Coca-Cola Company (KO) and T-Mobile US, Inc. (TMUS), as well as a micro-cap stock Preformed Line Products Company (PLPC).

Ahead of Amgen (AMGN) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Amgen (AMGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Kymera Therapeutics (KYMR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Lilly Stock a Portfolio Must Have Ahead of its Q3 Earnings?

Investor focus is likely to be on the sales numbers of LLY's tirzepatide medicines Mounjaro and Zepbound.

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

In the closing of the recent trading day, Amgen (AMGN) stood at $314.90, denoting a -1.49% change from the preceding trading day.

Amgen Gears Up to Report Q3 Earnings: Here's What to Expect

Volume growth from AMGN's key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.

Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

Why Amgen (AMGN) Dipped More Than Broader Market Today

Amgen (AMGN) reachead $316.74 at the closing of the latest trading day, reflecting a -1.53% change compared to its last close.

Ahan Chakraborty headshot

NVO Stock Falls 5% in a Month: Should Investors Buy Now or Wait?

Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the stellar performance of its GLP-1 drugs.

Kinjel Shah headshot

Lilly Loses Around $14B This Week: How to Play LLY Stock

Investors can buy LLY stock based on its strong overall financial performance and robust drug pipeline.

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Amgen (AMGN) closed at $325.09 in the latest trading session, marking a +0.14% move from the prior day.

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $321.01, marking a -0.43% move from the previous day.

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Smart Beta ETF report for IBB

Amgen (AMGN) Increases Yet Falls Behind Market: What Investors Need to Know

Amgen (AMGN) concluded the recent trading session at $319.66, signifying a +0.69% move from its prior day's close.

Why Amgen (AMGN) Dipped More Than Broader Market Today

In the most recent trading session, Amgen (AMGN) closed at $317.48, indicating a -0.7% shift from the previous trading day.

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.